Fundai

Dana Pharmaceutical Company (DEDANA) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DEDANA
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
Cash generated from operations38,427,5756,214,2613,671,7341,586,0051,034,2912,587,782
Cash payments for income tax-3,050,249-2,715,543-1,582,000-1,927,601-857,231-1,183,229
Net cash inflow (outflow) from operating activities35,377,3263,498,7182,089,734-341,596177,0601,404,553
Cash payments for purchase of property, plant and equipment-450,078-523,898-424,245-768,654-756,394-1,070,774
Cash receipts from interest on other investments5,5966,43724,8621,87516,9845,741
Net cash inflow (outflow) from investing activities-444,482-515,324-403,837-767,349-742,893-1,465,115
Net cash inflow (outflow) before financing activities34,932,8442,983,3941,685,897-1,108,945-565,833-60,562
Cash receipts from facilities42,626,88132,002,62022,051,61131,894,62915,025,3687,888,349
Cash payments for principal of loans-34,219,468-24,722,456-23,117,402-24,189,219-10,636,668-6,699,445
Cash payments for interest on loans-6,212,451-4,315,981-2,021,824-2,276,924-938,648-640,852
Cash payments for dividends-2,978,262-1,397,411-959,472-932,607-2,306,373-628,002
Net cash inflow (outflow) from financing activities-783,3001,566,772-4,047,0874,495,8791,143,679-79,950
Net increase (decrease) in cash34,149,5444,550,166-2,361,1903,386,934577,846-140,512
Cash balance at beginning of year3,773,6991,830,7734,011,8461,902,675830,947734,383
Effect of changes in exchange rates266,78353,142180,1173,9558,9291,754
Cash balance at end of year38,190,0266,434,0811,830,7735,293,5641,417,722595,625

Reporting periods

34 periods are on file for this report, from the period ending 1396/12/29 to the period ending 1405/06/31.